Personalized Medicine Innovation through Digital Enterprise Solutions

1. 22/11/2016

2. Horizon 2020 / INNOSUP-1-2015
• Topic
• Cluster facilitated projects for new value chains
• Aims
• Development of new cross-sectoral industrial value chains across the EU by
building upon the innovation potential of SMEs
• Promotion of cross-border and cross-sectoral collaboration, innovation and
entrepreneurship across different regions and value chains
• Coordination and facilitation by cluster organisations
2

3. Digitalization everywhere – also in Biopharma
• Personalized Medicine is the most promising approach
to develop therapies for severe diseases
• Advancing Personalized Medicine requires solutions
from IT sector
• e.g. big data, machine learning, IT security, data protection,
and cross-enterprise collaboration
• Biopharma and IT SMEs have a high innovation
potential, but lack knowledge about each others’
needs and potential solutions  innovation barriers
Cross-sectoral collaboration to overcome innovation
barriers and increase innovation potential of SMEs
3SMEs: small- and medium-sized enterprises, http://ec.europa.eu/growth/smes/business-friendly-environment/sme-definition_en

4. 4
Teaming up
to advance digital innovation

5. EUR 3,7 MIO for direct
innovation support for SMEs
EU Horizon 2020 Consortium
Attracted EUR 4,8 MIO for PERMIDES
projcect
5

6. Personalised Medicine Innovation through
Digital Enterprise Solutions - PERMIDES
• Aims
• Identification of innovation barriers regarding digitalization of the
biopharmaceutical value chain in personalized medicine
• Development of solution strategies
• Cross-linking of biopharma and IT SMEs to overcome these barriers
Building a joint cross-
sectoral and cross-boarder
understanding
Innovation support
• Open Calls
• Matchmaking Event
• Semantic Online Matchmaking
Platform
• Innovation Vouchers for
Innovation Projects
Follow-up coaching and
transfer to other SMEs
Stage 1
(Month 0-6)
Stage 2
(Month 7-18)
Stage 3
(Month 19-24)

7. Value Chain Challenges
• Data gathering and exchange – Provide access
to broad an complete data in real-time
• Big Data analytics & Machine Learning -
Generate actionable insights from massive data-
sets
• Development of novel data storage and mining
solutions
• Create novel production and supply solutions
for Personalised Medicine products
• Development of new business models and
marketing methods for Personalised Medicine
products
7

8. Digitalize biopharma SMEs via partnerships
• Open collaboration space: workshops,
semantic matchmaking portal, matchmaking
events and support
• Innovation voucher scheme: funding for
cross-sectoral collaborations
• 90+ innovation projects between IT and
biopharma companies
• Up to 60.000 EUR per project
8

9. Direct support for SMEs
Categories
• Travel voucher up to 1,800 €
Biopharma and IT SMEs can participate in matchmaking
events to find suitable partners
• Consultancy voucher up to 5,000 €
A biopharma SME can make use of an individual
consultation by an IT SME, regarding a specific challenge
in its value chain that could be improved via IT
• Prototyping voucher up to 30,000 €
A biopharma SME will order a prototype of a solution for
a specific challenge
• Customized solution voucher up to 60,000 €
A biopharma SME will receive a customized IT solution
adapted to its specific competitive situation
9

10. Direct support for SMEs
• Follow-up Coaching
• Provide access to further support measures and
other regional and national funding programs
• Dissemination
• Opportunity to present project results at
conferences (Digital Health Forums, Cluster
conferences)
• Press activities by the consortium
10

11. What’s next?
• Winter 2016/17 Workshops in Germany, Norway
and Austria
• Spring 2017 PERMIDES Platform launched,
matchmaking starts,
first calls for innovation projects
• Summer 2017 1st innovation voucher funding
granted
Website will be online in December: www.permides.eu
11

12. This project has received funding from the
European Union’s Horizon 2020 research
and innovation programme under grant
agreement No 691546